The banks have been quietly celebrating. The oil and gas giants are preparing fresh investment plans. The tech giants have ...

Pharmaceutical company shareholders were “spooked” this week after President-elect Donald Trump announced that he would ...

U.S. equity market futures were down for the week, while the 10-year U.S. Treasury yield hit its highest level in 5-1/2 months on Friday, as traders assessed Fe ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

When it comes to surveillance, PHAC said provincial and territorial public health agencies must report both “confirmed and ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

FTSE 100 and 250 decline as AstraZeneca and GSK weigh down. UK economy contracts in surprise September downturn, impacting growth prospects.

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

Cambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common ...

European shares fell on Friday, dragged down by disappointing earnings, concerns about the impact of U.S. President-elect Donald Trump's policies, and a jump in Treasury yields. Investors were also ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that he wants vaccine skeptic Robert F.

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...